The math is non linear, looks simple, but the drivers matter- More people taking GLP-1s- GLP-1 users in USA could rise to 15mn by 2030 if insurance expands and supply issues clear up More use cases- These drugs might work for more than obesity
Ozempic face Rapidly reducing the amount of fat in your face, as can happen when taking a GLP-1, can cause changes to your appearance often referred to as Ozempic face. You might notice changes such as: Reducing your weight slowly can reduce the likelihood of these facial changes happening
"GLP-1 therapy boosts visceral fat metabolism, driving weight loss"
It works by attaching to IGF-1 receptors on cells, which then activate key internal cell pathways, including PI3K-Akt and MAPK
Pattern across both trials Nausea, vomiting, and diarrhea peaked during dose escalation and tapered during maintenance
To learn more, see the When should I avoid Ozempic? section